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The Complete Genome Sequence of the Emerging Pathogen
Mycobacterium haemophilum Explains Its Unique Culture
Requirements
JoAnn M. Tufariello,a,b Christopher A. Kerantzas,a Catherine Vilchèze,a,c R. Brent Calder,d Eric K. Nordberg,e Jack A. Fischer,a
Travis E. Hartman,a Eva Yang,a Timothy Driscoll,f Laura E. Cole,a Robert Sebra,g Shahina B. Maqbool,h Alice R. Wattam,e
William R. Jacobs, Jr.a,c

ABSTRACT Mycobacterium haemophilum is an emerging pathogen associated with a variety of clinical syndromes, most com-

monly skin infections in immunocompromised individuals. M. haemophilum exhibits a unique requirement for iron supplementation to support its growth in culture, but the basis for this property and how it may shape pathogenesis is unclear. Using a
combination of Illumina, PacBio, and Sanger sequencing, the complete genome sequence of M. haemophilum was determined.
Guided by this sequence, experiments were performed to define the basis for the unique growth requirements of M. haemophilum. We found that M. haemophilum, unlike many other mycobacteria, is unable to synthesize iron-binding siderophores
known as mycobactins or to utilize ferri-mycobactins to support growth. These differences correlate with the absence of genes
associated with mycobactin synthesis, secretion, and uptake. In agreement with the ability of heme to promote growth, we identified genes encoding heme uptake machinery. Consistent with its propensity to infect the skin, we show at the whole-genome
level the genetic closeness of M. haemophilum with Mycobacterium leprae, an organism which cannot be cultivated in vitro, and
we identify genes uniquely shared by these organisms. Finally, we identify means to express foreign genes in M. haemophilum.
These data explain the unique culture requirements for this important pathogen, provide a foundation upon which the genome
sequence can be exploited to improve diagnostics and therapeutics, and suggest use of M. haemophilum as a tool to elucidate
functions of genes shared with M. leprae.
IMPORTANCE Mycobacterium haemophilum is an emerging pathogen with an unknown natural reservoir that exhibits unique
requirements for iron supplementation to grow in vitro. Understanding the basis for this iron requirement is important because
it is fundamental to isolation of the organism from clinical samples and environmental sources. Defining the molecular basis for
M. haemophilium’s growth requirements will also shed new light on mycobacterial strategies to acquire iron and can be exploited to define how differences in such strategies influence pathogenesis. Here, through a combination of sequencing and experimental approaches, we explain the basis for the iron requirement. We further demonstrate the genetic closeness of M. haemophilum and Mycobacterium leprae, the causative agent of leprosy which cannot be cultured in vitro, and we demonstrate
methods to genetically manipulate M. haemophilum. These findings pave the way for the use of M. haemophilum as a model to
elucidate functions of genes shared with M. leprae.
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M

ycobacterium haemophilum is a slow-growing acid-fast bacterium of the nontuberculous mycobacteria group that prefers a lower temperature for growth (30°C to 32°C) and requires
iron supplementation, typically either hemin or high concentrations of ferric ammonium citrate, for its growth (1–3). Like other
mycobacterial species that grow optimally at lower temperatures,
such as Mycobacterium marinum and Mycobacterium ulcerans,
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M. haemophilum is most associated with cutaneous infections of
the extremities (1, 4). Less common clinical manifestations of
M. haemophilum infection include skeletal infections, such as osteomyelitis and septic arthritis, pulmonary infections, ophthalmologic involvement, and disseminated disease (1, 5–11). These
cutaneous and extracutaneous manifestations occur primarily in
the setting of severe immune compromise (12). Some case reports
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RESULTS AND DISCUSSION

In vitro growth phenotypes. M. haemophilum requires iron supplementation for its growth. We explored the effect of different
iron sources by propagating M. haemophilum in heme-containing
7H9 liquid medium and then washing and plating the bacteria
onto various solid media. Unable to grow on oleic acid-albumindextrose-catalase (OADC)-enriched Middlebrook 7H10 agar
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FIG 1 M. haemophilum growth is supported by hemin and hemoglobin, but
not by mycobactin or carboxymycobactin. (A) M. haemophilum was plated
onto 7H10 medium without supplement; 7H10 medium supplemented with
100 M hemin, 2 g/ml mycobactin J (MbJ), or 100 M human hemoglobin
(Hg); or 5% sheep blood agar or chocolate agar. Photographs were taken after
~8 weeks of incubation at 30°C. (B) Growth of M. haemophilum, M. tuberculosis strain mc26230, or M. tuberculosis strain mc26230 with deletion of the
mbtB gene (⌬mbtB) on 7H10 medium containing 24 g/ml pantothenate
(pan) and without further supplement, or supplemented with the indicated
concentrations of hemin, MbJ, or M. smegmatis carboxymycobactin (cMb).

without other supplements, M. haemophilum grew well on 7H10
medium containing 100 M hemin (Fig. 1A). Growth was also
well-supported on 7H10 agar supplemented with human hemoglobin and on 5% sheep blood agar. Growth was somewhat less
abundant on chocolate agar (in which blood cells have been lysed
by heating) (Fig. 1A). These data are consistent with prior observations (2, 5, 26, 27).
Mycobacterium tuberculosis and other mycobacteria produce
siderophores, small iron-chelating compounds, termed mycobactins and carboxymycobactins, which bind and facilitate uptake of
environmental ferric iron (Fe3⫹). In one prior report, several
M. haemophilum clinical isolates failed to grow on LowensteinJensen (LJ) medium supplemented with mycobactin at 2 g/ml
(28), but earlier studies on one of the same isolates (prior to its
identification as M. haemophilum) reported that mycobactin did
support growth (29). We observed that M. haemophilum failed to
form colonies on 7H10 agar supplemented with 2 g/ml mycobactin J (from Mycobacterium avium subsp. paratuberculosis), but
it did form colonies with 100 M hemin (Fig. 1A). We also compared the growth properties of M. haemophilum with mc26230, an
M. tuberculosis H37Rv ⌬RD1 ⌬panCD auxotrophic strain that
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have also described a leprosy-like presentation of M. haemophilum
in immunocompromised individuals (13, 14). M. haemophilum
has also been reported to cause cervicofacial lymphadenitis in immunocompetent children (15) and adults (16).
Infection with M. haemophilum occurs worldwide and, although it has been until now an infrequently isolated pathogen,
the incidence appears to be rising since its initial discovery in 1978
(2). This likely reflects the emergence of severe immune compromise due to HIV/AIDS or in the settings of bone marrow/solid
organ transplantation, hematologic malignancy, or treatment
with disease-modifying agents for rheumatologic disorders (8, 12,
17–22), all of which predispose to infection with this opportunistic pathogen. At present there is no standardized protocol for in
vitro susceptibility testing (1), although recommendations for a
disk agar elution method for M. haemophilum are included in a
recent Clinical and Laboratory Standards Institute (CLSI) document (23). Further, it is unknown how predictive the results are of
clinical outcomes. Optimal treatment regimens also remain undefined (1); however, there is a general consensus that patients
should receive a combination of agents that appear to be active in
vitro, such as clarithromycin, ciprofloxacin, and a rifamycin, for a
prolonged duration (~12 to 24 months) which is tailored to the
individual’s presentation and degree of immune compromise (1,
12, 24, 25). For immunocompetent patients with lymph node involvement, surgical excision may be sufficient (1, 12). The natural
habitat/reservoir of M. haemophilum as well as its mode of transmission also remain poorly defined. While many nontuberculous
mycobacteria are found in soil and aquatic habitats, attempts to
recover M. haemophilum from environmental samples have often
proven unsuccessful, although this may be attributed in part to the
slow growth of the organism and its fastidious growth requirements (1).
Very little genetic information has been available for M. haemophilum. This limits understanding of its unique growth requirements and how these properties shape its pathogenesis. We
therefore determined the complete genome sequence of the
M. haemophilum DSM 44634 type strain and performed accompanying experiments that implicated the absence of mycobactin
synthesis machinery, which in other mycobacteria plays a critical
role in iron acquisition, as a major factor in the iron dependence of
this organism. Further analysis demonstrated a close evolutionary
relationship with Mycobacterium leprae and identified both genetic features conserved with other mycobacteria and also unique
features that reflect the specific biology of this emerging pathogen.
The data also provide groundwork for the development of improved diagnostic tests that will facilitate understanding of the
pathogenesis, epidemiology, and mode of transmission of this
emerging pathogen. Finally, as a first step toward experimental use
of this genetic information, we identify means to introduce and
express foreign genetic material in M. haemophilum, which should
allow exploitation of this organism as a means to study gene products uniquely shared with M. leprae.

Mycobacterium haemophilum Complete Genome Sequence
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cluster, are also present in M. haemophilum (Fig. 3A). However,
the M. haemophilum mbtJ and mbtI homologues are in a locus
physically distant from the mbtH homologue, separated by greater
than 600 kb. MbtJ is a putative acetyl hydrolase whose precise role
in mycobactin synthesis remains unclear (35). MbtI, the first enzyme in the mycobactin synthesis pathway, is a salicylate synthase
(39). M. haemophilum does not possess a full-length mbtI gene but
does contain an open reading frame encoding a product with homology to the C-terminal portion of MbtI (88% identity to the
C-terminal 100 amino acids of the H37Rv MbtI). This region also
shares homology with TrpE (anthranilite synthase, which catalyzes the first committed step in tryptophan biosynthesis) and
other enzymes which act on chorismate in a variety of metabolic
pathways (39). Therefore, this gene might participate in a different
metabolic pathway.
Mycobactin synthesis: mbt-2 (mbtK-mbtN) gene cluster. Although M. tuberculosis mbt-1 encodes enzymes necessary for synthesis of the mycobactin backbone, it lacks genes encoding enzymes that attach the fatty acyl chain. These components of the
siderophore biosynthetic machinery lie within the mbt-2 (mbtKmbtN) gene cluster (34). The entire mbt-2 gene cluster appears to
be absent in M. haemophilum (Fig. 3B). Together with the absence
of mbtG, mbtF, mbtE, mbtD, mbtC, mbtB, and mbtA homologues,
the absence of all four genes comprising the mbt-2 cluster makes it
highly unlikely that M. haemophilum is capable of synthesizing
mycobactin siderophores. Interestingly, the only mycobacterial
species with similarly extensive deletions of the mbt-1 and mbt-2
regions are M. leprae (40) and the recently identified and closely
related M. lepromatosis (41, 42), both of which have genomes
characterized by extreme reductive evolution.
Functional analysis of mycobactin synthesis. To experimentally address production of mycobactin or carboxymycobactin by
M. haemophilum, we cultured the bacteria under iron-replete conditions followed by transfer to iron-limited medium containing
the radiolabeled mycobactin precursor [7-14C]salicylic acid. The
iron-limited medium should, based on data from M. tuberculosis
(43), increase expression of the mycobactin synthesis machinery.
M. tuberculosis mc26230, which has intact mycobactin synthesis,
secretion, and uptake systems, was grown under similar conditions and served as a control. We tested two growth conditions:
chelated 7H9 (see the supplemental text describing further materials and methods) in the presence and absence of 10 M hemin.
We expected that the latter might afford better growth while still
imposing iron restriction. Cell-associated and secreted siderophores extracted from cell pellets and culture filtrates were analyzed by thin-layer chromatography (TLC). Because M. haemophilum failed to grow as well as mc26230 in the iron-limited
medium, even with the addition of 10 M hemin, the two M. haemophilum cultures were pooled for siderophore extraction. TLC
analysis revealed an absence of mycobactin or carboxymycobactin
production by M. haemophilum under the growth conditions
tested, in either the cell pellet or the culture supernatant (Fig. 4).
For mc26230, both mycobactin and carboxymycobactin were
present in the cell pellet, with smaller amounts in the culture supernatant. These findings are the first direct evidence for lack of
mycobactin/carboxymycobactin production by M. haemophilum.
Due to relatively poor growth of M. haemophilum compared with
mc26230 in the iron-limited medium, a significantly smaller cell
mass was analyzed; however, despite equal radioactive label on
material being run on the TLC, there was still a complete absence
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requires pantothenate supplementation (7H10-pan) and can be
used under biosafety level 2 (BSL2) containment (30, 31), with
those of a ⌬mbtB mutant strain generated in the mc26230 background which lacks an essential component of the mycobactin
synthesis pathway (32). Whereas mc26230 grew well under all
conditions tested, the ⌬mbtB mutant failed to grow on 7H10-pan
but did grow on 7H10-pan supplemented with 100 M hemin,
2 g/ml mycobactin J, and 200 ng/ml M. smegmatis carboxymycobactin (Fig. 1B). In contrast, M. haemophilum was unable to
grow with either mycobactin J or carboxymycobactin supplementation, although again, growth was abundant on 100 M hemin
(Fig. 1B). These results suggest a defect(s) in the uptake and/or
utilization of siderophore-bound iron by M. haemophilum.
In several experiments, inoculation of M. haemophilum onto
7H10 medium supplemented with 15 mg/ml ferric ammonium
citrate (FAC) resulted in absent or very suboptimal growth (data
not shown). Others have observed growth of M. haemophilum on
LJ medium supplemented with 15 mg/ml FAC but not on 7H10
medium with the same concentration of FAC (28, 33). Conversely, although 7H10 supplemented with hemin supports
growth, it has been observed that LJ with hemin does not (27, 28,
33). These findings suggest that interactions occur between particular iron complexes and other components of the media.
Overview of the M. haemophilum genome. To gain further
insights into its growth requirements, the complete M. haemophilum genome sequence was determined. The genome consists of a
single circular chromosome of 4,235,765 bp with an average GC
content of 63.9% and encodes an estimated 3,964 genes (NCBI
Prokaryotic Genome Annotation Pipeline). Pertinent characteristics of the genome in comparison with other mycobacterial species
are listed in Table S1 in the supplemental material. Functional
assignments using database comparisons were obtained for approximately two-thirds of coding sequences, with the remainder
encoding hypothetical proteins (Rapid Annotation Using Subsystem Technology, or RAST [National Microbial Pathogen Data
Resource]). Gene numbers referred to in the text are those assigned by RAST under Genome ID 1202450.9. A representation of
the M. haemophilum chromosome is shown in Fig. 2, including
the orientation of the coding sequences, percent GC content, and
GC skew.
Mycobactin synthesis: mbt-1 (mbtA-mbtJ) gene cluster. In
M. tuberculosis, the salicylate-based mycobactin siderophores are
synthesized by enzymes encoded in two distinct gene clusters,
mbt-1 (mbtA-mbtJ) and mbt-2 (mbtK-mbtN) (34, 35). One striking feature of the M. haemophilum genome is the absence of close
homologues of almost all of the 14 genes comprising these two
mycobactin synthesis clusters (Fig. 3A and B). For the mbtA-mbtJ
cluster, close homologues of 7 of the 10 genes—mbtG, mbtF,
mbtE, mbtD, mbtC, mbtB, and mbtA—appear to be missing in
M. haemophilum (Fig. 3A). An open reading frame (ORF) encoding a putative protein with significant homology to MbtH, found
at one end of the mbtA-mbtJ locus in H37Rv, does appear to be
present [with 78% identity to H37Rv MbtH (Rv2377c) over
71 amino acids]. However, the product of this gene may not function in mycobactin synthesis, as homologues in other bacteria,
such as actinomycetes and a rapid-growing mycobacterium, Mycobacterium smegmatis, have been implicated in other pathways,
such as synthesis of cell wall glycopeptidolipids (36–38).
For the remainder of the mbt-1 gene cluster, close homologues
of mbtJ and mbtI, found at the opposite end of the H37Rv gene

Tufariello et al.

Downloaded from http://mbio.asm.org/ on May 7, 2020 by guest
FIG 2 Circular representation of the M. haemophilum chromosome. Concentric rings, numbered from outer to inner rings, show the following: 1, scale (in
megabases) starting at the top center and running clockwise; 2, forward coding sequences (CDS), in dark green; 3, reverse CDS, in light green; 4, GC content
(percentage) as a line plot, with axes from 20% (inner) to 80% (outer), with lines every 15%, where the dark orange background indicates a GC content above
50%; 5, GC skew of genes as a line plot symmetrical about a skew of 1. The plot was generated using the CIRCOS circular genome data visualization program and
the genome sequence as submitted for annotation by RAST.

of mycobactin and carboxymycobactin detected in the M. haemophilum samples, and the only radiolabeled species associated with
the cell pellet was [14C]salicylate. The suboptimal growth of
M. haemophilum in iron-limited medium is, in itself, consistent
with a lack of siderophore production by the strain. The M. haemophilum genome, like that of M. tuberculosis, appears to lack a
gene cluster homologous to that present in the rapid-growing
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M. smegmatis which encodes the synthesis of the non-salicylatecontaining peptidic exochelin siderophores (44–46); however, the
possibility that M. haemophilum synthesizes an alternative siderophore is not excluded.
Mycobactin uptake and secretion: IrtA/B and MmpL/MmpS
proteins. Adjacent to the mbt-2 gene cluster in M. tuberculosis
H37Rv are the iron-regulated transporter A (irtA; Rv1348) and
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FIG 3 Comparison of mbt-1 and mbt-2 gene clusters in M. tuberculosis and M. haemophilum. (A) M. haemophilum lacks major portions of mycobactin synthesis
cluster 1 (mbt-1). The M. haemophilum genomic region corresponding to mbt-1 was compared to the analogous region of M. tuberculosis H37Rv. Genes of the
mbt-1 cluster are shown on a background of yellow shading. Scale bar, 1,000 nucleotides (nt). (B) M. haemophilum lacks the entirety of mycobactin synthesis
cluster 2 (mbt-2) and adjacent irtA-irtB. The M. haemophilum genomic region corresponding to mbt-2 was compared to the analogous regions of M. tuberculosis
H37Rv and M. leprae. Genes of the mbt-2 cluster are shown on a background of yellow shading. Scale bar, 500 nt. In panels A and B, arrows indicate genes and
gene orientation, while arrow colors indicate functional roles of the genes, according to the key at the bottom of the diagram. Conserved genes flanking the mbt-1
and mbt-2 loci are on a background of purple shading.

irtB (Rv1349) genes, which are cotranscribed (47) and, along with
the mbt-1 and mbt-2 clusters, are part of the IdeR regulon, with
their transcription repressed under iron-replete conditions (43,
48). irtA and irtB appear to encode an ABC transporter which
participates in the uptake and utilization of siderophore-bound
iron and enables growth under iron-deficient conditions (49).
Homologues of irtA and irtB are lacking in M. haemophilum
(Fig. 3B), again similar to M. leprae.
Recently, members of the mycobacterial membrane protein
large (MmpL) and small (MmpS) families have been found to play
a role in the secretion of mycobacterial siderophores (50). M. haemophilum encodes close counterparts of MmpL4 (Mh0573) and
MmpS4 (Mh0574), located immediately adjacent to one another.
However, although there are additional mmpL and mmpS genes,
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we were unable to identify equally close homologues of MmpL5
and MmpS5, which contribute to siderophore synthesis and secretion in M. tuberculosis (50). Notably, MmpS4 is also required
for export of cell surface glycopeptidolipids in M. smegmatis (51).
Therefore, M. haemophilum MmpS4/MmpL4 homologues may
participate in transport of substances other than mycobactins.
Heme uptake, utilization, and biosynthesis. Recently, a heme
acquisition system involving a secreted heme-binding protein
(Rv0203) and the transmembrane proteins MmpL11 (Rv0202c)
and MmpL3 (Rv0206c) was identified for M. tuberculosis (52).
M. haemophilum encodes homologues of Rv0203 (Mh0273),
MmpL11 (Mh0272), and MmpL3 (Mh0276), located in close
proximity to one another, similar to their counterparts in H37Rv.
M. haemophilum also encodes a homologue (Mh3902) of the
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Mb

.h

M

cell pellet

supernatant

FIG 4 M. haemophilum does not produce mycobactin. Synthesis and release
of mycobactin was assessed by culturing M. tuberculosis strain mc26230 or
M. haemophilum in iron-deficient media, conditions that induced mycobactin
synthesis for M. tuberculosis. [14C]salicylate was added to cultures to label
newly synthesized mycobactin, and extracts of bacterial pellets and culture
supernatants were analyzed by TLC by loading equal activity (counts per minute). Lane 1, mc26230 cell pellet; lane 2, M. haemophilum cell pellet; lane 3,
mc26230 supernatant; lane 4, M. haemophilum supernatant; lane 5,
[14C]salicylate. Indicated are the expected locations of mycobactin (Mb) and
carboxymycobactin (cMb) from M. smegmatis, based on migration of purified
nonradioactive standards (data not shown).

M. tuberculosis MhuD (mycobacterial heme utilization, degrader;
Rv3592), which binds to and degrades heme (53). Therefore, our
genome sequence data reveal intact heme uptake and utilization
systems in M. haemophilum, in agreement with the results of the
growth studies reported here. This in contrast to M. leprae, which,
although it encodes homologues of MmpL11 and MmpL3, appears to lack a counterpart to the secreted heme-binding protein
Rv0203 (40), suggesting a possible deficiency in the scavenging of
heme-iron. M. haemophilum also appears to possess close homologues of M. tuberculosis H37Rv genes that encode putative heme
biosynthetic pathway components (see Table S2 in the supplemental material), and again this differs from M. leprae, which is
missing the hemN gene (42), and therefore may be impaired in
heme biosynthesis.
ESX loci including ESX-3. Type VII secretion systems (T7SSs)
encoded within ESX loci permit transport of proteins across the
lipid-rich cell envelope to the cell surface or external environment.
The ESX loci are large gene clusters which code for the ATPdependent secretory apparatuses needed to export members of the
6-kDa early secretory antigenic target (ESAT-6)/culture filtrate
protein 10 (CFP-10) protein families (EsxA/EsxB of the ESX-1
region and their paralogues), as well as a number of additional/
associated substrates which remain to be fully defined. M. tuberculosis possesses five ESX systems, encoded within gene clusters
designated ESX-1 to ESX-5, several of which play important roles
in M. tuberculosis pathogenesis and intracellular survival (54).
M. haemophilum possesses homologues of all five ESX systems
(see Table S3 in the supplemental material).
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The ESX-3 locus of M. haemophilum is of particular interest,
because it has been implicated in iron and zinc homeostasis in
M. tuberculosis (55–57). M. tuberculosis esx-3 expression is regulated by the availability of iron and zinc, under control of both the
IdeR repressor and the zinc uptake regulator Zur/FurB (Rv2359)
(58). ESX-3 is likely necessary for the uptake and/or utilization of
iron bound to mycobactin (57), although involvement in alternative mycobacterial metal ion uptake processes has also been suggested (59, 60). The absence of genes required for mycobactin
synthesis and mycobactin uptake/export in M. haemophilum
makes a largely intact ESX-3 locus in M. haemophilum noteworthy
(Fig. 5). Of the 11 ORFs in the M. tuberculosis ESX-3 region, 10
have close homologues in the corresponding region of M. haemophilum, including genes encoding both EsxG and EsxH, which are
believed to be secreted as a heterodimeric complex (57, 61), similar to the EsxA-EsxB secreted effectors of the ESX-1 region.
All ESX loci with the exception of the smallest and most archaic, ESX-4, possess a pe-ppe gene pair adjacent to the esx gene
pair (54); these are named for the conserved proline-glutamic acid
(PE) and proline-proline-glutamic acid (PPE) residues found
near the N termini of the encoded proteins. The only gene which is
absent from its expected location within the ESX-3 region of
M. haemophilum is ppe4 (Rv0286), the ppe component of the peppe pair present within the M. tuberculosis H37Rv ESX-3 locus
(Fig. 5). The significance of this absence with regard to the irondependent growth phenotype of the organism and the inability of
mycobactin to support growth (Fig. 1A and B) is unclear, because
the functions of the pe and ppe gene families remain largely obscure. It is possible that this deficiency is compensated by ppe
homologues encoded elsewhere in the genome. Notably, M. haemophilum does possess a ppe gene immediately upstream of the
ESX-3 locus.
Although the M. haemophilum genome shares with M. tuberculosis the presence of five ESX loci, there are some differences
from the corresponding M. tuberculosis ESX regions. The primary
difference is that several of the pe and ppe genes are absent from
M. haemophilum, such as an absent pe35 homologue within the
ESX-1 locus and an absent ppe4 in the ESX-3 locus, although some
of the regions differ in other respects as well (see Table S3 in the
supplemental material). For ESX-2, homologues of all 12 of the
corresponding M. tuberculosis genes are present, but the region is
discontinuous, similar to findings for M. avium subsp. paratuberculosis (62).
Genes present in M. haemophilum but absent from M. tuberculosis H37Rv that may be related to iron acquisition. Comparison of the M. haemophilum genome with other mycobacterial
species revealed a number of genes present in M. haemophilum but
absent from M. tuberculosis H37Rv. These included several genes
with potential roles in iron acquisition. One, Mh1776, is annotated as ferrous iron transport protein B (feoB) and encodes a
protein with significant homology to an integral component of the
Feo inner membrane transport system, which functions in the
uptake of ferrous (Fe2⫹) iron (63, 64). Although this system has
been best studied in enteric Gram-negative bacteria such as Escherichia coli and Salmonella species (65, 66), genes encoding the Feo
system have been identified in more than 40% of sequenced bacterial genomes (64).
In E. coli, the Feo system contains three genes encoded in the
locus feoABC; although in other bacterial genomes, feoC is often
absent (64). This is the situation for M. haemophilum, which con-
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FIG 5 Comparison of esx-3 loci from M. haemophilum, M. tuberculosis, and M. leprae. The M. haemophilum esx-3 genomic region was compared to the
analogous regions of M. tuberculosis H37Rv and M. leprae. Genes of the esx-3 cluster are shown on a background of yellow shading. Conserved genes flanking the
esx-3 locus are on a background of purple shading. Arrows indicate genes and gene orientations. Arrow colors indicate functional roles of the genes, according
to the key at the bottom of the diagram. Scale bar, 1,000 nucleotides (nt).

tains adjacent feoA (Mh1777) and feoB (Mh1776) genes, but has
no obvious feoC paralogue. Ferrous iron is thought to be transported across the cytoplasmic membrane by the GTP-dependent
permease FeoB (67). The small hydrophilic FeoA protein appears
to interact with FeoB and to be required for transport (68). The
presence of FeoA and FeoB suggests that M. haemophilum may
encounter conditions (anaerobic and/or acidic) in its in vivo niche
that increase the availability of ferrous iron, or perhaps that the
bacterium is capable of reducing extracellular ferric ions to promote uptake by this system. Although absent in M. tuberculosis
and M. leprae, BLAST analysis identifies homologues of FeoA and
FeoB in a number of nontuberculous mycobacteria, including
M. kansasii, M. marinum, M. genavense, and M. xenopi.
M. haemophilum also possesses a second natural resistanceassociated macrophage protein (Nramp) family member. Nramps
were initially identified in eukaryotes as integral membrane proteins that function as pH-dependent high-affinity divalent metal
ion transporters (69–71). Many bacteria also possess Nramp family members (72, 73), including M. tuberculosis, which has a single
homologue (74–76). This is in contrast to M. leprae which, even
with its small genome size, bears two copies of a mntH/nramp
homologue (40); our sequencing results demonstrated that this is
also true for M. haemophilum (Mh0166 and Mh3510), which occupies a somewhat similar in vivo niche. These conserved Nramp
homologues are candidate iron uptake factors.
Iron uptake in bacteria is both critical and complex, characterized by the presence of multiple transport systems which may be
utilized under different environmental conditions (77). In addition to the systems described above, it is likely that M. haemophilum encodes additional gene products involved in iron uptake.
For instance, M. haemophilum encodes a locus (Mh0534Mh0536) with homology to ATP-binding cassette (ABC) transport systems of the iron/siderophore/heme/vitamin B12 type
(78), including putative permease (Mh0536) and ATP-binding
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(Mh0535) components as well as a putative substrate binding protein (Mh0534) homologous to proteins that play roles in iron
uptake in other bacteria. Interestingly, this locus is absent in both
M. tuberculosis and M. leprae. Future studies examining growth in
the presence of ferrous iron and transcriptional responses of
M. haemophilum under iron-replete versus iron-limited conditions and aerobic versus hypoxic conditions may help clarify the
contributions of the gene products described above and identify
additional genes involved in novel iron uptake pathways. Ultimately, it may also be informative to compare in vitro gene expression profiles to those obtained during intracellular and in vivo
growth, to help elucidate mechanisms of iron acquisition in the
context of infection.
Evolutionary relationships of M. haemophilum. Previous
phylogenetic analyses based on limited available sequence data,
such as rpoB gene comparisons, have suggested a close evolutionary relationship between M. haemophilum and M. leprae (79, 80).
Our complete genome sequence data confirm the closeness of
this relationship. A phylogenetic tree constructed by wholechromosome comparison to 14 selected mycobacterial genomes
using the BLAST algorithm revealed the closest neighbors to
M. haemophilum DSM 44634/ATCC 29548 to be the M. leprae
strains TN and B4923 and the recently identified M. lepromatosis
(Fig. 6). This is also consistent with the genetic similarities detailed
above and with analyses of fatty acid compositions and phenolic
glycolipid contents of the organisms (81–83). However, at ~4.23
Mb, the genome of M. haemophilum is substantially larger than
the ~3.27-Mb genomes of M. leprae and M. lepromatosis. The latter have both undergone extensive pseudogenization, of about
approximately 50% of the genome (40, 42), while for M. haemophilum pseudogenes account for only ~7% of the total (NCBI
Prokaryotic Genome Annotation Pipeline) (see Table S1 in the
supplemental material). This suggests that the described reductive
evolution of M. leprae and M. lepromatosis was not shared with the
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M. leprae
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FIG 6 Phylogenetic tree of selected mycobacterial species. A phylogenetic tree was constructed for 15 mycobacterial genomes, including M. haemophilum, and
one outgroup genome as described in Materials and Methods. The scale (0.025) indicates substitutions per aligned position.
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nostics might be improved by designing additional PCR-based,
hybridization-based, and antigen-based tests for M. haemophilum
by using information derived from the complete genome sequence. This information may also enable improved epidemiological and environmental testing, expanding the molecular tools

FIG 7 Successful transformation of M. haemophilum. (A) M. haemophilum was transformed with an integrating vector conferring hygromycin
resistance (pMV361-hyg), an episomal vector conferring kanamycin resistance (pMV261-kan), an integrating vector conferring kanamycin resistance
(pMV361-kan), or an episomal vector conferring kanamycin resistance and
expressing the red fluorescent protein tdTomato from the M. marinum G13
promoter (pYUB1169). Colonies were photographed after 24 days of incubation at 30°C, while colonies harboring the tdTomato-expressing construct
were photographed again at 33 days postincubation, to demonstrate intensification of the pink color. No-DNA controls demonstrating sensitivity of
M. haemophilum to kanamycin and hygromycin at the indicated concentrations are also shown. In addition to antibiotic supplements, all plates also
contained 100 M hemin. (B) M. haemophilum transformed with the tdTomato fluoresce red. Images were obtained with a Nikon Eclipse TiE microscope using a CFI Plan Apo VC 100⫻/1.40 numerical aperture objective and a
BrightLine Ex56240 filter set. The fluorescent image is shown on the left and a
differential interference contrast image is on the right.
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common ancestor, but instead began after divergence of M. haemophilum from the other two species.
Expression of foreign genes in M. haemophilum. Exploiting
the genome sequence of and developing M. haemophilum into a
model system could expand our understanding of its pathophysiology and allow new insights into M. leprae, which cannot be
cultivated in vitro. Therefore, we explored whether we could
transform M. haemophilum by electroporation, using protocols
established for other slow-growing mycobacteria. Transformations with “empty vector” plasmid DNAs demonstrated abundant
recovery of colonies when we used 100 g/ml kanamycin (for
pMV261-kan and pMV361-kan) or 100 g/ml hygromycin (for
pMV361-hyg) as selection agents (Fig. 7A). The no-DNA control
transformations yielded no colonies at ~3 weeks of incubation,
although with extended incubation small colonies appeared on
the kanamycin-supplemented plates, indicating that higher antibiotic concentrations may be preferable. We noted the attB site
(integration site for the pMV361 vectors) of M. haemophilum was
identical to that of M. smegmatis. Integration of pMV361-kan and
pMV361-hyg was confirmed by PCR across the attB locus and
sequencing of products (data not shown). We also transformed
M. haemophilum with an episomal plasmid expressing the tdTomato fluorescent protein under control of the M. marinum G13
promoter, a strong constitutive mycobacterial promoter that
yields high expression levels (84). We found tdTomato to be very
highly expressed, as indicated by the intense pink color of the
colonies, which deepened further with extended incubation
(Fig. 7A). Fluorescence of transformants was confirmed by microscopy (Fig. 7B), revealing a characteristic mycobacterial cording. These data provide the first demonstration that M. haemophilum can be genetically manipulated with molecular tools
established for other mycobacterial species and establish a foundation upon which the sequence data obtained here can be exploited to study this unique human pathogen.
Conclusions. Fundamental to understanding M. haemophilum as a pathogen are defining the basis for its unique growth
requirements and its relationships to other mycobacteria. Our
sequence and experimental data provide insight into the requirement of M. haemophilum for specific iron supplements, which
may contribute to its modest virulence in immunocompetent individuals. The sequence data provided here may also facilitate
diagnostics. Current molecular diagnostic approaches for detection of M. haemophilum in clinical samples utilize PCR-based
methods (85, 86) and rely on very limited sequence information. Because there may be genetic diversity among M. haemophilum isolates from different geographic areas (87–89), diag-
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available to evaluate diversity. Our findings also demonstrate a
close genetic relationship between M. haemophilum and M. leprae,
the latter an important human pathogen that cannot be propagated in vitro. The successful transformation of M. haemophilum
coupled with the genomic sequence will facilitate studies to elucidate the features that contribute to the pathogenic properties of
M. haemophilum and allow its use as a surrogate to functionally
characterize gene products uniquely shared by M. haemophilum
and M. leprae.
MATERIALS AND METHODS

November/December 2015 Volume 6 Issue 6 e01313-15

SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
lookup/suppl/doi:10.1128/mBio.01313-15/-/DCSupplemental.
Text S1, DOCX file, 0.1 MB.
Table S1, DOCX file, 0.03 MB.
Table S2, DOCX file, 0.02 MB.
Table S3, DOCX file, 0.04 MB.

ACKNOWLEDGMENTS
This work was supported by National Institutes of Health grants AI26170
and AI098925 to W.R.J.
We thank David Reynolds, Director of the Genomics Core Facility at
the Albert Einstein College of Medicine, for helpful discussions on genome finishing and Colin Ratledge for generously providing the M. smegmatis mycobactin.

REFERENCES
1. Lindeboom JA, Bruijnesteijn van Coppenraet LES, van Soolingen D,
Prins JM, Kuijper EJ. 2011. Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev
24:701–717. http://dx.doi.org/10.1128/CMR.00020-11.
2. Sompolinsky D, Lagziel A, Naveh D, Yankilevitz T. 1978. Mycobacterium haemophilum sp. nov., a new pathogen of humans. Int J Syst Bacteriol 28:67–75. http://dx.doi.org/10.1099/00207713-28-1-67.
3. Sompolinsky D, Lagziel A, Rosenberg I. 1979. Further studies of a new
pathogenic mycobacterium (M. Haemophilum sp. nov.). Can J Microbiol
25:217–226. http://dx.doi.org/10.1139/m79-033.
4. Davis BR, Brumbach J, Sanders WJ, Wolinsky E. 1982. Skin lesions
caused by Mycobacterium haemophilum. Ann Intern Med 97:723–724.
http://dx.doi.org/10.7326/0003-4819-97-5-723.
5. Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D. 1996.
Mycobacterium haemophilum: microbiology and expanding clinical and
geographic spectra of disease in humans. Clin Microbiol Rev 9:435– 447.
6. Fairhurst RM, Kubak BM, Pegues DA, Moriguchi JD, Han KF, Haley JC,
Kobashigawa JA. 2002. Mycobacterium haemophilum infections in heart transplant recipients: case report and review of the literature. Am J Transplant
2:476–479. http://dx.doi.org/10.1034/j.1600-6143.2002.20514.x.
7. Hirsch R, Miller S, Kazi S, Cate T, Reveille J. 1996. Human immunodeficiency
virus-associatedatypicalmycobacterialskeletalinfections.SeminArthritisRheum
25:347–356. http://dx.doi.org/10.1016/S0049-0172(96)80020-5.
8. White MH, Papadopoulos EB, Small TN, Kiehn TE, Armstrong D.
1995. Mycobacterium haemophilum infections in bone marrow transplant recipients. J Transplant 60:957–960.
9. Elsayed S, Read R. 2006. Mycobacterium haemophilum osteomyelitis:
case report and review of the literature. BMC Infect Dis 6:70. http://
dx.doi.org/10.1186/1471-2334-6-70.
10. Sogani J, Ivanidze J, Phillips CD. 2014. Chiasmitis caused by Mycobacterium haemophilum in an immunocompromised adult. Clin Imaging
38:727–729. http://dx.doi.org/10.1016/j.clinimag.2014.02.012.
11. Ducharlet K, Murphy C, Tan S, Dwyer KM, Goodman D, Aboltins C,
Daffy JR, Langham RG. 2014. Recurrent Mycobacterium haemophilum
in a renal transplant recipient. Nephrology 19(Suppl 1):14 –17. http://
dx.doi.org/10.1111/nep.12193.
12. Shah M, Sebti A, Kiehn T, Massarella S, Sepkowitz K. 2001. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis
33:330 –337. http://dx.doi.org/10.1086/321894.
13. Copeland NK, Arora NS, Ferguson TM. 2013. Mycobacterium haemophilum masquerading as leprosy in a renal transplant patient. Case Rep
Dermatol Med 2013:793127. http://dx.doi.org/10.1155/2013/793127.
14. Ishii K, Ishii N, Nakanaga K, Nakano K, Saito I, Asahina A. 2015.
Mycobacterium haemophilum infection with prominent facial manifes-

®

mbio.asm.org 9

Downloaded from http://mbio.asm.org/ on May 7, 2020 by guest

Bacterial strains. The Mycobacterium haemophilum type strain (DSM
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⌬mbtB were supplemented with 24 g/ml D-pantothenate (Sigma).
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bromide-chloroform-based method (90) was sequenced by the Epigenomics Shared Facility (ESF) at the Albert Einstein College of Medicine,
using MiSeq (Illumina), and at the Department of Genetics and Genomic
Sciences, Icahn School of Medicine at Mount Sinai, using PacBio methodologies. Details of genome sequencing, assembly, and annotation are
provided in Text S1 in the supplemental material.
Phylogenetic analysis. A phylogenetic tree was constructed for 15
mycobacterial genomes, including that of M. haemophilum and one outgroup genome. Further details concerning our materials and methods are
provided in Text S1 in the supplemental material.
Protocol for plating on various media types. M. haemophilum bacteria cultured in 7H9-hemin were pelleted by centrifugation and washed in
phosphate-buffered saline (PBS) containing 0.05% tyloxapol or 0.05%
Tween 80 (PBS-T), following which equal inocula were plated onto the
various media being tested. Details are provided in the Text S1 in the
supplemental material.
Transformation of M. haemophilum. M. haemophilum transformation was performed according to methods developed for M. tuberculosis
(90), except M. haemophilum was grown at 30°C. See Text S1 in the supplemental material for details.
Examination of mycobactin and carboxymycobactin synthesis and
secretion based on use of a radiolabeled precursor. M. haemophilum and
strain mc26230 were cultured in 7H9 medium without hemin in order to
deplete iron stores, following which bacteria were transferred to ironlimited 7H9 medium (treated overnight with the iron chelator Chelex100; details are provided in Text S1 in the supplemental material). Bacteria were inoculated at a starting optical density at 600 nm of 0.3 in 5 ml of
medium in the presence of 1 Ci/ml [7-14C]salicylic acid (PerkinElmer)
and grown with shaking for 20 days at 37°C for mc26230 and at 30°C for
M. haemophilum. For M. haemophilum, cultures were prepared in duplicate, one lacking iron sources and one containing 10 M hemin. Siderophores were extracted according to the method of Wells et al. (50) (see
Text S1 for further details regarding our materials and methods). Extracts
from cell pellets and culture supernatants were resuspended in chloroform and spotted on TLC silica gel 60F254 plates, with samples normalized
based on equivalent radioactivity levels.
Nucleotide sequence accession numbers. Sequence data were deposited in the NCBI repository under BioProject PRJNA171821 (Mycobacterium haemophilum DSM 44634, ATCC 29548). The complete genome
sequence is available under accession number CP011883. Short Illumina reads, Illumina mate-pair reads, Pacific Biosciences SMRT reads,

and Sanger sequencing information were deposited in the NCBI Sequence Read Archive (SRA) under accession numbers SRX1059681,
SRX1059688, SRX1059690, and SRX1059710, respectively. Genome annotations were deposited on the RAST website (http://rast.nmpdr.org/)
(91, 92), first under Genome ID 1202450.3 and later updated to begin the
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Tufariello et al.

15.
16.

17.
18.
19.

21.

22.

23.
24.

25.

26.

27.
28.
29.
30.

31.

10

®

mbio.asm.org

32.

33.
34.

35.

36.

37.

38.

39.

40.

41.

42.

43.

44.

45.
46.

47.

compromised mice against experimental tuberculosis. Vaccine 24:
6309 – 6320. http://dx.doi.org/10.1016/j.vaccine.2006.05.097.
De Voss JJ, Rutter K, Schroeder BG, Su H, Zhu Y, Barry CE, III. 2000.
The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci U S A
97:1252–1257. http://dx.doi.org/10.1073/pnas.97.3.1252.
Mezo A, Jennis F, McCarthy SW, Dawson DJ. 1979. Unusual mycobacteria in 5 cases of opportunistic infections. Pathology 11:377–384. http://
dx.doi.org/10.3109/00313027909059014.
Krithika R, Marathe U, Saxena P, Ansari MZ, Mohanty D, Gokhale RS.
2006. A genetic locus required for iron acquisition in Mycobacterium
tuberculosis. Proc Natl Acad Sci U S A 103:2069 –2074. http://dx.doi.org/
10.1073/pnas.0507924103.
Quadri LEN, Sello J, Keating TA, Weinreb PH, Walsh CT. 1998.
Identification of a Mycobacterium tuberculosis gene cluster encoding the
biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin. Chem Biol 5:631– 645. http://dx.doi.org/10.1016/
S1074-5521(98)90291-5.
Chavadi SS, Stirrett KL, Edupuganti UR, Vergnolle O, Sadhanandan G,
Marchiano E, Martin C, Qiu W-, Soll CE, Quadri LEN. 2011. Mutational and phylogenetic analyses of the mycobacterial mbt gene cluster. J
Bacteriol 193:5905–5913. http://dx.doi.org/10.1128/JB.05811-11.
Felnagle EA, Barkei JJ, Park H, Podevels AM, McMahon MD, Drott
DW, Thomas MG. 2010. MbtH-like proteins as integral components of
bacterial nonribosomal peptide synthetases. Bio Chem 49:8815– 8817.
http://dx.doi.org/10.1021/bi1012854.
Tatham E, Chavadi S, Mohandas P, Edupuganti UR, Angala SK, Chatterjee D, Quadri LEN. 2012. Production of mycobacterial cell wall glycopeptidolipids requires a member of the MbtH-like protein family. BMC
Microbiol 12:118. http://dx.doi.org/10.1186/1471-2180-12-118.
Harrison AJ, Yu M, Gardenborg T, Middleditch M, Ramsay RJ, Baker
EN, Lott JS. 2006. The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin,
reveals it to be a salicylate synthase. J Bacteriol 188:6081– 6091. http://
dx.doi.org/10.1128/JB.00338-06.
Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR,
Honoré N, Garnier T, Churcher C, Harris D, Mungall K, Basham D,
Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S,
Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K,
Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA,
Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K,
Whitehead S, Woodward JR, Barrell BG. 2001. Massive gene decay in the
leprosy bacillus. Nature 409:1007–1011. http://dx.doi.org/10.1038/
35059006.
Han XY, Seo Y, Sizer KC, Schoberle T, May GS, Spencer JS, Li W, Nair
RG. 2008. A new mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol 130:856 – 864. http://dx.doi.org/10.1309/
AJCPP72FJZZRRVMM.
Singh P, Benjak A, Schuenemann VJ, Herbig A, Avanzi C, Busso P,
Nieselt K, Krause J, Vera-Cabrera L, Cole ST. 2015. Insight into the
evolution and origin of leprosy bacilli from the genome sequence of mycobacterium lepromatosis. Proc Natl Acad Sci U S A 112:4459 – 4464.
http://dx.doi.org/10.1073/pnas.1421504112.
Gold B, Rodriguez GM, Marras SAE, Pentecost M, Smith I. 2001. The
Mycobacterium tuberculosis IdeR is a dual functional regulator that controls transcription of genes involved in iron acquisition, iron storage and
survival in macrophages. Mol Microbiol 42:851– 865. http://dx.doi.org/
10.1046/j.1365-2958.2001.02684.x.
Fiss EH, Yu S, Jacobs WR, Jr. 1994. Identification of genes involved in the
sequestration of iron in mycobacteria: the ferric exochelin biosynthetic
and uptake pathways. Mol Microbiol 14:557–569. http://dx.doi.org/
10.1111/j.1365-2958.1994.tb02189.x.
Yu S, Fiss E, Jacobs WR, Jr. 1998. Analysis of the exochelin locus in
Mycobacterium smegmatis: biosynthesis genes have homology with genes
of the peptide synthetase family. J Bacteriol 180:4676 – 4685.
Zhu W, Arceneaux JEL, Beggs ML, Byers BR, Eisenach KD, Lundrigan
MD. 1998. Exochelin genes in Mycobacterium smegmatis: identification of an
ABC transporter and two non-ribosomal peptide synthetase genes. Mol Microbiol 29:629 – 639. http://dx.doi.org/10.1046/j.1365-2958.1998.00961.x.
Farhana A, Kumar S, Rathore SS, Ghosh PC, Ehtesham NZ, Tyagi
AK, Hasnain SE. 2008. Mechanistic insights into a novel exporterimporter system of Mycobacterium tuberculosis unravel its role in

November/December 2015 Volume 6 Issue 6 e01313-15

Downloaded from http://mbio.asm.org/ on May 7, 2020 by guest

20.

tation mimicking leprosy. J Dermatol 42:992–995. http://dx.doi.org/
10.1111/1346-8138.12948.
Dawson DJ, Blacklock ZM, Kane DW. 1981. Mycobacterium haemophilum causing lymphadenitis in an otherwise healthy child. Med J Aust
2:289 –290.
Minani TJC, Saubolle MA, Yu E, Sussland Z. 2010. Mycobacterium
haemophilum as a novel etiology of cervical lymphadenitis in an otherwise
healthy adult patient. J Clin Microbiol 48:2636 –2639. http://dx.doi.org/
10.1128/JCM.00814-10.
Kelley CF, Armstrong WS, Eaton ME. 2011. Disseminated Mycobacterium haemophilum infection. Lancet Infect Dis 11:571–578. http://
dx.doi.org/10.1016/S1473-3099(11)70029-9.
Kiehn TE, White M. 1994. Mycobacterium haemophilum: an emerging
pathogen. Eur J Clin Microbiol Infect Dis 13:925–931. http://dx.doi.org/
10.1007/BF02111493.
Kamboj M, Louie E, Kiehn T, Papanicolaou G, Glickman M, Sepkowitz
K. 2008. Mycobacterium haemophilum infection after alemtuzumab
treatment. Emerg Infect Dis 14:1821–1823. http://dx.doi.org/10.3201/
eid1411.071321.
Aslam A, Green RL, Motta L, Ghrew M, Griffiths CEM, Warren RB.
2013. Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis. Br J Dermatol 168:446 – 447. http://
dx.doi.org/10.1111/j.1365-2133.2012.11164.x.
Collins CS, Terrell C, Mueller P. 2013. Disseminated Mycobacterium
haemophilum infection in a 72-year-old patient with rheumatoid arthritis
on infliximab. BMJ Case Rep 2013:bcr2012008034. http://dx.doi.org/
10.1136/bcr-2012-008034.
Brissot E, Gomez A, Aline-Fardin A, Lalande V, Lapusan S, Isnard F,
Legrand O, Meynard J, Rubio M, Mohty M. 2014. Report of disseminated Mycobacterium haemophilum infection after double cord blood
allo-SCT. Bone Marrow Transplant 49:1347–1348. http://dx.doi.org/
10.1038/bmt.2014.144.
CLSI. 2011. Susceptibility testing of mycobacteria, nocardiae, and other
aerobic actinomycetes; approved standard M24-A2, 2nd ed. Clinical and
Laboratory Standards Institute, Wayne, PA.
Barr LK, Sharer LR, Khadka Kunwar E, Kapila R, Zaki SR, Drew CP,
Bhatnagar J, Liu JK, Chew D. 2015. Intraventricular granulomatous mass
associated with Mycobacterium haemophilum: a rare central nervous system manifestation in a patient with human immunodeficiency virus infection. J Clin Neurosci 22:1057–1060. http://dx.doi.org/10.1016/
j.jocn.2014.11.036.
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C,
Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman
M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr., Winthrop K,
ATSMD Subcommittee, American Thoracic Society—Infectious Diseases Society of America. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
Am J Respir Crit Care Med 175:367– 416. http://dx.doi.org/10.1164/
rccm.200604-571ST.
Sampaio JLM, Alves VAF, Leão SC, De Magalhaes V, Martino MDV,
Mendes CMF, Misiara ACdO, Miyashiro K, Pasternak J, Rodrigues E,
Rozenbaum R, Filho CAS, Teixeira SRM, Xavier AC, Figueiredo MS,
Leite JPG. 2002. Mycobacterium haemophilum: emerging or underdiagnosed in Brazil? Emerg Infect Dis 8:1359 –1360. http://dx.doi.org/
10.3201/eid0811.020492.
Vadney FS, Hawkins JE. 1985. Evaluation of a simple method for growing
Mycobacterium haemophilum. J Clin Microbiol 22:884 – 885.
Dawson DJ, Jennis F. 1980. Mycobacteria with a growth requirement for
ferric ammonium citrate, identified as Mycobacterium haemophilum. J
Clin Microbiol 11:190 –192.
Walder BK, Jeremy D, Charlesworth JA, Macdonald GJ, Pussell BA,
Robertson MR. 1976. The skin and immunosuppression. Australas J Dermatol 17:94 –97. http://dx.doi.org/10.1111/j.1440-0960.1976.tb00798.x.
Jain P, Hartman TE, Eisenberg N, O’Donnell MR, Kriakov J, Govender
K, Makume M, Thaler DS, Hatfull GF, Sturm AW, Larsen MH, Moodley P, Jacobs WR, Jr. 2012. Phi(2)GFP10, a high-intensity fluorophage,
enables detection and rapid drug susceptibility testing of Mycobacterium
tuberculosis directly from sputum samples. J Clin Microbiol 50:
1362–1369. http://dx.doi.org/10.1128/JCM.06192-11.
Sambandamurthy VK, Derrick SC, Hsu T, Chen B, Larsen MH, Jalapathy KV, Chen M, Kim J, Porcelli SA, Chan J, Morris SL, Jacobs WR, Jr.
2006. Mycobacterium tuberculosis ⌬RD1 ⌬panCD: a safe and limited
replicating mutant strain that protects immunocompetent and immuno-

Mycobacterium haemophilum Complete Genome Sequence

48.

49.
50.

51.

53.

54.
55.

56.

57.

58.

59.
60.
61.

62.

63.
64.
65.
66.
67.

November/December 2015 Volume 6 Issue 6 e01313-15

68.
69.

70.

71.

72.

73.

74.

75.

76.

77.
78.
79.

80.
81.

82.
83.
84.

85.

86.

membrane protein FeoB contains an intramolecular G protein essential
for Fe(II) uptake in bacteria. Proc Natl Acad Sci U S A 99:16243–16248.
http://dx.doi.org/10.1073/pnas.242338299.
Kim H, Lee H, Shin D. 2012. The FeoA protein is necessary for the FeoB
transporter to import ferrous iron. Biochem Biophys Res Commun 423:
733–738. http://dx.doi.org/10.1016/j.bbrc.2012.06.027.
Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron
WF, Nussberger S, Gollan JL, Hediger MA. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature
388:482– 488. http://dx.doi.org/10.1038/41343.
Supek F, Supekova L, Nelson H, Nelson N. 1996. A yeast manganese
transporter related to the macrophage protein involved in conferring resistance to mycobacteria. Proc Natl Acad Sci U S A 93:5105–5110. http://
dx.doi.org/10.1073/pnas.93.10.5105.
Supek F, Supekova L, Nelson H, Nelson N. 1997. Function of metal-ion
homeostasis in the cell division cycle, mitochondrial protein processing,
sensitivity to mycobacterial infection and brain function. J Exp Biol 200:
321–330.
Makui H, Roig E, Cole ST, Helmann JD, Gros P, Cellier MFM. 2000.
Identification of the Escherichia coli K-12 Nramp orthologue (MntH) as a
selective divalent metal ion transporter. Mol Microbiol 35:1065–1078.
http://dx.doi.org/10.1046/j.1365-2958.2000.01774.x.
Kehres DG, Zaharik ML, Finlay BB, Maguire ME. 2000. The NRAMP
proteins of Salmonella typhimurium and Escherichia coli are selective manganese transporters involved in the response to reactive oxygen. Mol Microbiol 36:1085–1100. http://dx.doi.org/10.1046/j.1365-2958.2000.01922.x.
Agranoff D, Monahan IM, Mangan JA, Butcher PD, Krishna S. 1999.
Mycobacterium tuberculosis expresses a novel pH-dependent divalent
cation transporter belonging to the Nramp family. J Exp Med 190:
717–724. http://dx.doi.org/10.1084/jem.190.5.717.
Boechat N, Lagier-Roger B, Petit S, Bordat Y, Rauzier J, Hance AJ,
Gicquel B, Reyrat J-. 2002. Disruption of the gene homologous to mammalian Nramp1 in Mycobacterium tuberculosis does not affect virulence
in mice. Infect Immun 70:4124 – 4131. http://dx.doi.org/10.1128/
IAI.70.8.4124-4131.2002.
Domenech P, Pym AS, Cellier M, Barry CE III, Cole ST. 2002. Inactivation
of the Mycobacterium tuberculosis Nramp orthologue (mntH) does not affect virulence in a mouse model of tuberculosis. FEMS Microbiol Lett 207:
81– 86. http://dx.doi.org/10.1111/j.1574-6968.2002.tb11032.x.
Braun V, Hantke K. 2011. Recent insights into iron import by bacteria.
Curr Opin Chem Biol 15:328 –334. http://dx.doi.org/10.1016/
j.cbpa.2011.01.005.
Köster W. 2001. ABC transporter-mediated uptake of iron, siderophores,
heme and vitamin B12. Res Microbiol 152:291–301. http://dx.doi.org/
10.1016/S0923-2508(01)01200-1.
Han XY, Sizer KC, Thompson EJ, Kabanja J, Li J, Hu P, Gomez-Valero
L, Silva FJ. 2009. Comparative sequence analysis of Mycobacterium leprae
and the new leprosy-causing mycobacterium lepromatosis. J Bacteriol
191:6067– 6074. http://dx.doi.org/10.1128/JB.00762-09.
Mignard S, Flandrois J-. 2008. A seven-gene, multilocus, genus-wide
approach to the phylogeny of mycobacteria using supertrees. Int J Syst
Evol Microbiol 58:1432–1441. http://dx.doi.org/10.1099/ijs.0.65658-0.
Besra GS, McNeil M, Minnikin DE, Portaels F, Ridell M, Brennan PJ.
1991. Structural elucidation and antigenicity of a novel phenolic glycolipid antigen from Mycobacterium haemophilum. Biochemistry 30:
7772–7777. http://dx.doi.org/10.1021/bi00245a015.
Kusaka T, Izumi S. 1983. Gaschromatography of constitutive fatty acids
in Mycobacterium leprae. Microbiol Immunol 27:409 – 414. http://
dx.doi.org/10.1111/j.1348-0421.1983.tb00599.x.
Portaels F, Dawson DJ, Larsson L, Rigouts L. 1993. Biochemical properties and fatty acid composition of Mycobacterium haemophilum: study
of 16 isolates from Australian patients. J Clin Microbiol 31:26 –30.
Barker LP, Porcella SF, Wyatt RG, Small PLC. 1999. The Mycobacterium marinum G13 promoter is a strong sigma 70-like promoter that is
expressed in Escherichia coli and mycobacteria species. FEMS Microbiol
Lett 175:79 – 85. http://dx.doi.org/10.1111/j.1574-6968.1999.tb13604.x.
Bruijnesteijn Van Coppenraet ES, Lindeboom JA, Prins JM, Peeters
MF, Claas ECJ, Kuijper EJ. 2004. Real-time PCR assay using fine-needle
aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial
lymphadenitis in children. J Clin Microbiol 42:2644 –2650. http://
dx.doi.org/10.1128/JCM.42.6.2644-2650.2004.
Wang SX, Sng LH, Leong HN, Tan BH. 2004. Direct identification of
Mycobacterium haemophilum in skin lesions of immunocompromised

®

mbio.asm.org 11

Downloaded from http://mbio.asm.org/ on May 7, 2020 by guest

52.

trafficking of iron. PLoS One 3:e2087. http://dx.doi.org/10.1371/
journal.pone.0002087.
Rodriguez GM, Voskuil MI, Gold B, Schoolnik GK, Smith I. 2002. ideR,
an essential gene in mycobacterium tuberculosis: role of IdeR in irondependent gene expression, iron metabolism, and oxidative stress response. Infect Immun 70:3371–3381. http://dx.doi.org/10.1128/
IAI.70.7.3371-3381.2002.
Rodriguez GM, Smith I. 2006. Identification of an ABC transporter required for
iron acquisition and virulence in Mycobacterium tuberculosis. J Bacteriol 188:
424–430. http://dx.doi.org/10.1128/JB.188.2.424-430.2006.
Wells RM, Jones CM, Xi Z, Speer A, Danilchanka O, Doornbos KS, Sun
P, Wu F, Tian C, Niederweis M. 2013. Discovery of a siderophore export
system essential for virulence of Mycobacterium tuberculosis. PLoS Pathog 9:e1003120. http://dx.doi.org/10.1371/journal.ppat.1003120.
Deshayes C, Bach H, Euphrasie D, Attarian R, Coureuil M, Sougakoff W,
Laval F, Av-Gay Y, Daffé M, Etienne G, Reyrat J. 2010. MmpS4 promotes
glycopeptidolipids biosynthesis and export in Mycobacterium smegmatis. Mol
Microbiol 78:989–1003. http://dx.doi.org/10.1111/j.1365-2958.2010.07385.x.
Tullius MV, Harmston CA, Owens CP, Chim N, Morse RP, McMath
LM, Iniguez A, Kimmey JM, Sawaya MR, Whitelegge JP, Horwitz MA,
Goulding CW. 2011. Discovery and characterization of a unique mycobacterial heme acquisition system. Proc Natl Acad Sci U S A 108:
5051–5056. http://dx.doi.org/10.1073/pnas.1009516108.
Chim N, Iniguez A, Nguyen TQ, Goulding CW. 2010. Unusual diheme
conformation of the heme-degrading protein from Mycobacterium tuberculosis. J Mol Biol 395:595– 608. http://dx.doi.org/10.1016/
j.jmb.2009.11.025.
Simeone R, Bottai D, Frigui W, Majlessi L, Brosch R. 2015. ESX/type VII
secretion systems of mycobacteria: insights into evolution, pathogenicity
and protection. Tuberculosis (Edinb) doi:10.1016/j.tube.2015.02.019.
Serafini A, Boldrin F, Palu G, Manganelli R. 2009. Characterization of a
Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and
rescue by iron and zinc. J Bacteriol 191:6340 – 6344. http://dx.doi.org/
10.1128/JB.00756-09.
Serafini A, Pisu D, Palu G, Rodriguez GM, Manganelli R. 2013. The
ESX-3 secretion system is necessary for iron and zinc homeostasis in Mycobacterium tuberculosis. PLoS One 8:e78351. http://dx.doi.org/10.1371/
journal.pone.0078351.
Siegrist MS, Unnikrishnan M, McConnell MJ, Borowsky M, Cheng T-,
Siddiqi N, Fortune SM, Moody DB, Rubin EJ. 2009. Mycobacterial Esx-3
is required for mycobactin-mediated iron acquisition. Proc Natl Acad Sci
U S A 106:18792–18797. http://dx.doi.org/10.1073/pnas.0900589106.
Maciag A, Dainese E, Rodriguez GM, Milano A, Provvedi R, Pasca MR,
Smith I, Palu G, Riccardi G, Manganelli R. 2007. Global analysis of the
Mycobacterium tuberculosis Zur (FurB) regulon. J Bacteriol 189:
730 –740. http://dx.doi.org/10.1128/JB.01190-06.
Stoop EJM, Bitter W, van der Sar AM. 2012. Tubercle bacilli rely on a
type VII army for pathogenicity. Trends Microbiol 20:477– 484. http://
dx.doi.org/10.1016/j.tim.2012.07.001.
Houben ENG, Korotkov KV, Bitter W. 2014. Take five—type VII secretion systems of mycobacteria. Biochim Biophys Acta 1843:1707–1716
http://dx.doi.org/10.1016/j.bbamcr.2013.11.003.
Ilghari D, Lightbody KL, Veverka V, Waters LC, Muskett FW, Renshaw
PS, Carr MD. 2011. Solution structure of the Mycobacterium tuberculosis
EsxG.EsxH complex: functional implications and comparisons with other
M. tuberculosis Esx family complexes. J Biol Chem 286:29993–30002.
http://dx.doi.org/10.1074/jbc.M111.248732.
Bitter W, Houben ENG, Bottai D, Brodin P, Brown EJ, Cox JS,
Derbyshire K, Fortune SM, Gao L, Liu J, Gey van Pittius NC, Pym AS,
Rubin EJ, Sherman DR, Cole ST, Brosch R. 2009. Systematic genetic
nomenclature for type VII secretion systems. PLoS Pathog 5:e1000507.
http://dx.doi.org/10.1371/journal.ppat.1000507.
Hantke K. 2003. Is the bacterial ferrous iron transporter FeoB a living fossil?
Trends Microbiol 11:192–195. http://dx.doi.org/10.1016/S0966-842X
(03)00100-8.
Cartron ML, Maddocks S, Gillingham P, Craven CJ, Andrews SC. 2006.
Feo: transport of ferrous iron into bacteria. Biometals 19:143–157. http://
dx.doi.org/10.1007/s10534-006-0003-2.
Hantke K. 1987. Ferrous iron transport mutants in Escherichia coli K12. FEMS
Microbiol Lett 44:53–57. http://dx.doi.org/10.1111/j.1574-6968.1987.tb02241.x.
Kammler M, Schon C, Hantke K. 1993. Characterization of the ferrous
iron uptake system of Escherichia coli. J Bacteriol 175:6212– 6219.
Marlovits TC, Haase W, Herrmann C, Aller SG, Unger VM. 2002. The

Tufariello et al.

87.

88.
89.
90.

patients by PCR-restriction endonuclease analysis. J Clin Microbiol 42:
3336 –3338. http://dx.doi.org/10.1128/JCM.42.7.3336-3338.2004.
Bruijnesteijn van Coppenraet LES, Savelkoul PHM, Buffing N, van der
Bijl MW, Woudenberg J, Lindeboom JA, Kiehn TE, Haverkort F, Samra
Z, Kuijper EJ. 2009. Amplified fragment length polymorphism analysis of
human clinical isolates of Mycobacterium haemophilum from different
continents. Clin Microbiol Infect 15:924 –930. http://dx.doi.org/10.1111/
j.1469-0691.2009.02798.x.
Kikuchi K, Bernard EM, Kiehn TE, Armstrong D, Riley LW. 1994.
Restriction fragment length polymorphism analysis of clinical isolates of
Mycobacterium haemophilum. J Clin Microbiol 32:1763–1767.
Yakrus MA, Straus WL. 1994. DNA polymorphisms detected in Mycobacterium haemophilum by pulsed-field gel electrophoresis. J Clin Microbiol 32:1083–1084.
Larsen MH, Biermann K, Tandberg S, Hsu T, Jacobs WR. 2007. Genetic

manipulation of Mycobacterium tuberculosis. Curr Protoc Microbiol 6:A:
10A.2:10A.2.1–10A.2.21.
91. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA,
Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson
R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T,
Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V,
Wilke A, Zagnitko O. 2008. The RAST server: rapid annotations using
subsystems technology. BMC Genomics 9:75. http://dx.doi.org/10.1186/
1471-2164-9-75.
92. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, Edwards
RA, Gerdes S, Parrello B, Shukla M, Vonstein V, Wattam AR, Xia F,
Stevens R. 2014. The SEED and the rapid annotation of microbial genomes using subsystems technology (RAST). Nucleic Acids Res 42:
D206 –D214. http://dx.doi.org/10.1093/nar/gkt1226.

Downloaded from http://mbio.asm.org/ on May 7, 2020 by guest

12

®

mbio.asm.org

November/December 2015 Volume 6 Issue 6 e01313-15

